COVID-19 Disease in Presenting to the Pediatric Emergency Department : A Multicenter Study of 8886 Cases
Copyright © 2022 Elsevier Inc. All rights reserved..
BACKGROUND: The aim was to evaluate the epidemiological, clinical, laboratory, and radiologic data of children with SARS-CoV-2 positivity by polymerase chain reaction (PCR) together with treatment strategies and clinical outcomes and to evaluate cases of multisystem inflammatory syndrome in children (MIS-C) in this population.
METHODS: This was a multicenter retrospective observational cohort study performed in the pediatric emergency departments of 19 tertiary hospitals. From March 11, 2020, to May 31, 2021, children who were diagnosed with confirmed nasopharyngeal/tracheal specimen SARS-CoV-2 PCR positivity or positivity for serum-specific antibodies against SARS-CoV-2 were included. Demographics, presence of chronic illness, symptoms, history of contact with SARS-CoV-2 PCR-positive individuals, laboratory and radiologic investigations, clinical severity, hospital admissions, and prognosis were recorded.
RESULTS: A total of 8886 cases were included. While 8799 (99.0%) cases resulted in a diagnosis of SARS-CoV-2 with PCR positivity, 87 (1.0%) patients were diagnosed with MIS-C. Among SARS-CoV-2 PCR-positive patients, 51.0% were male and 8.5% had chronic illnesses. The median age was 11.6 years (IQR: 5.0-15.4) and 737 (8.4%) patients were aged <1 year. Of the patients, 15.5% were asymptomatic. The most common symptoms were fever (48.5%) and cough (30.7%) for all age groups. There was a decrease in the rate of fever as age increased (p < 0.001); the most common age group for this symptom was <1 year with the rate of 69.6%. There was known contact with a SARS-CoV-2 PCR-positive individual in 67.3% of the cases, with household contacts in 71.3% of those cases. In terms of clinical severity, 83 (0.9%) patients were in the severe-critical group. There was hospital admission in 1269 (14.4%) cases, with 106 (1.2%) of those patients being admitted to the pediatric intensive care unit (PICU). Among patients with MIS-C, 60.9% were male and the median age was 6.4 years (IQR: 3.9-10.4). Twelve (13.7%) patients presented with shock. There was hospital admission in 89.7% of these cases, with 29.9% of the patients with MIS-C being admitted to the PICU.
CONCLUSION: Most SARS-CoV-2 PCR-positive patients presented with a mild clinical course. Although rare, MIS-C emerges as a serious consequence with frequent PICU admission. Further understanding of the characteristics of COVID-19 disease could provide insights and guide the development of therapeutic strategies for target groups.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
The American journal of emergency medicine - 59(2022) vom: 24. Sept., Seite 133-140 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Duman, Murat [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 09.08.2022 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajem.2022.06.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM343701553 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM343701553 | ||
| 003 | DE-627 | ||
| 005 | 20231226021049.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajem.2022.06.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM343701553 | ||
| 035 | |a (NLM)35849960 | ||
| 035 | |a (PII)S0735-6757(22)00382-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Duman, Murat |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 Disease in Presenting to the Pediatric Emergency Department |b A Multicenter Study of 8886 Cases |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.08.2022 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: The aim was to evaluate the epidemiological, clinical, laboratory, and radiologic data of children with SARS-CoV-2 positivity by polymerase chain reaction (PCR) together with treatment strategies and clinical outcomes and to evaluate cases of multisystem inflammatory syndrome in children (MIS-C) in this population | ||
| 520 | |a METHODS: This was a multicenter retrospective observational cohort study performed in the pediatric emergency departments of 19 tertiary hospitals. From March 11, 2020, to May 31, 2021, children who were diagnosed with confirmed nasopharyngeal/tracheal specimen SARS-CoV-2 PCR positivity or positivity for serum-specific antibodies against SARS-CoV-2 were included. Demographics, presence of chronic illness, symptoms, history of contact with SARS-CoV-2 PCR-positive individuals, laboratory and radiologic investigations, clinical severity, hospital admissions, and prognosis were recorded | ||
| 520 | |a RESULTS: A total of 8886 cases were included. While 8799 (99.0%) cases resulted in a diagnosis of SARS-CoV-2 with PCR positivity, 87 (1.0%) patients were diagnosed with MIS-C. Among SARS-CoV-2 PCR-positive patients, 51.0% were male and 8.5% had chronic illnesses. The median age was 11.6 years (IQR: 5.0-15.4) and 737 (8.4%) patients were aged <1 year. Of the patients, 15.5% were asymptomatic. The most common symptoms were fever (48.5%) and cough (30.7%) for all age groups. There was a decrease in the rate of fever as age increased (p < 0.001); the most common age group for this symptom was <1 year with the rate of 69.6%. There was known contact with a SARS-CoV-2 PCR-positive individual in 67.3% of the cases, with household contacts in 71.3% of those cases. In terms of clinical severity, 83 (0.9%) patients were in the severe-critical group. There was hospital admission in 1269 (14.4%) cases, with 106 (1.2%) of those patients being admitted to the pediatric intensive care unit (PICU). Among patients with MIS-C, 60.9% were male and the median age was 6.4 years (IQR: 3.9-10.4). Twelve (13.7%) patients presented with shock. There was hospital admission in 89.7% of these cases, with 29.9% of the patients with MIS-C being admitted to the PICU | ||
| 520 | |a CONCLUSION: Most SARS-CoV-2 PCR-positive patients presented with a mild clinical course. Although rare, MIS-C emerges as a serious consequence with frequent PICU admission. Further understanding of the characteristics of COVID-19 disease could provide insights and guide the development of therapeutic strategies for target groups | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Children | |
| 650 | 4 | |a Infection | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Şık, Nihan |e verfasserin |4 aut | |
| 700 | 1 | |a Tekşam, Özlem |e verfasserin |4 aut | |
| 700 | 1 | |a Akça, Halise |e verfasserin |4 aut | |
| 700 | 1 | |a Kurt, Funda |e verfasserin |4 aut | |
| 700 | 1 | |a Çağlar, Ayla Akca |e verfasserin |4 aut | |
| 700 | 1 | |a Yıldız, Leman Akcan |e verfasserin |4 aut | |
| 700 | 1 | |a Taşar, Medine Ayşin |e verfasserin |4 aut | |
| 700 | 1 | |a Fidancı, İlknur |e verfasserin |4 aut | |
| 700 | 1 | |a Yayla, Burcu Ceylan Cura |e verfasserin |4 aut | |
| 700 | 1 | |a Yılmaz, Durgül |e verfasserin |4 aut | |
| 700 | 1 | |a Güngör, Emre |e verfasserin |4 aut | |
| 700 | 1 | |a Demir, Şule |e verfasserin |4 aut | |
| 700 | 1 | |a Çokuğraş, Haluk |e verfasserin |4 aut | |
| 700 | 1 | |a Cebeci, Sinem Oral |e verfasserin |4 aut | |
| 700 | 1 | |a Önal, Pınar |e verfasserin |4 aut | |
| 700 | 1 | |a Saz, Eylem Ulaş |e verfasserin |4 aut | |
| 700 | 1 | |a Yurtseven, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Uysalol, Metin |e verfasserin |4 aut | |
| 700 | 1 | |a Yıldız, Raif |e verfasserin |4 aut | |
| 700 | 1 | |a Gümüş, Süheyla |e verfasserin |4 aut | |
| 700 | 1 | |a Bal, Alkan |e verfasserin |4 aut | |
| 700 | 1 | |a Bayturan, Semra Şen |e verfasserin |4 aut | |
| 700 | 1 | |a Zengin, Neslihan |e verfasserin |4 aut | |
| 700 | 1 | |a Atik, Sinem |e verfasserin |4 aut | |
| 700 | 1 | |a Çiftdoğan, Dilek Yılmaz |e verfasserin |4 aut | |
| 700 | 1 | |a Berksoy, Emel |e verfasserin |4 aut | |
| 700 | 1 | |a Çiçek, Alper |e verfasserin |4 aut | |
| 700 | 1 | |a Şahin, Sabiha |e verfasserin |4 aut | |
| 700 | 1 | |a Kızıl, Mahmut Can |e verfasserin |4 aut | |
| 700 | 1 | |a Kara, Yalçın |e verfasserin |4 aut | |
| 700 | 1 | |a Apa, Hurşit |e verfasserin |4 aut | |
| 700 | 1 | |a Ulusoy, Emel |e verfasserin |4 aut | |
| 700 | 1 | |a Kara, Aybüke Akaslan |e verfasserin |4 aut | |
| 700 | 1 | |a Yesil, Edanur |e verfasserin |4 aut | |
| 700 | 1 | |a Erdem, Meltem |e verfasserin |4 aut | |
| 700 | 1 | |a Turan, Caner |e verfasserin |4 aut | |
| 700 | 1 | |a Arslanoglu, Sertac |e verfasserin |4 aut | |
| 700 | 1 | |a Duyu, Muhterem |e verfasserin |4 aut | |
| 700 | 1 | |a Besli, Gulser Esen |e verfasserin |4 aut | |
| 700 | 1 | |a Arslan, Gazi |e verfasserin |4 aut | |
| 700 | 1 | |a Oflu, Ayşe Tolunay |e verfasserin |4 aut | |
| 700 | 1 | |a Çeleğen, Mehmet |e verfasserin |4 aut | |
| 700 | 1 | |a Buldu, Ebru |e verfasserin |4 aut | |
| 700 | 1 | |a Pişkin, İbrahim Etem |e verfasserin |4 aut | |
| 700 | 1 | |a Kardeş, Hakan |e verfasserin |4 aut | |
| 700 | 1 | |a Yılmaz, Hayri Levent |e verfasserin |4 aut | |
| 700 | 1 | |a Yıldızdaş, Dinçer |e verfasserin |4 aut | |
| 700 | 1 | |a Gökulu, Gamze |e verfasserin |4 aut | |
| 700 | 1 | |a Çay, Pınar |e verfasserin |4 aut | |
| 700 | 1 | |a Özer, Utku |e verfasserin |4 aut | |
| 700 | 1 | |a Güleryüz, Okşan Derinöz |e verfasserin |4 aut | |
| 700 | 1 | |a Çolak, Özlem |e verfasserin |4 aut | |
| 700 | 1 | |a Güneysu, Songül Tomar |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of emergency medicine |d 1986 |g 59(2022) vom: 24. Sept., Seite 133-140 |w (DE-627)NLM01297868X |x 1532-8171 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2022 |g day:24 |g month:09 |g pages:133-140 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajem.2022.06.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2022 |b 24 |c 09 |h 133-140 | ||